Consumer medicine information

Lomide

Lodoxamide

BRAND INFORMATION

Brand name

Lomide Eye Drops

Active ingredient

Lodoxamide

Schedule

S2

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Lomide.

SUMMARY CMI

LOMIDE® Eye Drops 0.1%

Consumer Medicine Information (CMI) summary

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist.

1. Why am I using Lomide?

Lomide contains the active ingredient lodoxamide trometamol. Lomide eye drops are used to treat certain eye problems such as seasonal allergic conjunctivitis and vernal keratoconjunctivitis or spring catarrh.

For more information, see Section 1. Why am I using Lomide? in the full CMI.

2. What should I know before I use Lomide?

Do not use if you have ever had an allergic reaction to Lomide or any of the ingredients listed at the end of the CMI.

Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.

For more information, see Section 2. What should I know before I use Lomide? in the full CMI.

3. What if I am taking other medicines?

Some medicines may interfere with Lomide and affect how it works.

A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.

4. How do I use Lomide?

  • Use one drop in each eye, four times a day at regular intervals.
  • Follow the instructions provided and use Lomide eye drops until your doctor tells you to stop.

More instructions can be found in Section 4. How do I use Lomide? in the full CMI.

5. What should I know while using Lomide?

Things you should do
  • Remind any doctor, dentist, pharmacist or optometrist you visit that you are using Lomide eye drops.
  • Call your doctor immediately if you develop any signs of allergic reactions such as swelling of the face, lips, tongue or other parts of the body, rash, hives.
  • Do not touch the dropper tip to any surface to avoid contamination.
Things you should not do
  • Do not stop using this medicine suddenly.
  • Do not put Lomide eye drops in your eyes if you are wearing contact lenses as it may cause irritation to your eyes and discolor the soft contact lenses
  • Do not give Lomide eye drops to anyone else, even if they seem to have the same condition as you.
Driving or using machines
  • Precaution should be taken before you drive or use any machines or tools.
  • Lomide eye drops may cause temporary blurred vision or other eye problems in some people.
  • Wait until vision clears before driving or using machinery.
Looking after your medicine
  • Store below 25°C.
  • Do not freeze the eye drops.
  • Discard any remaining eye drops after 28 days after opening it.

For more information, see Section 5. What should I know while using Lomide? in the full CMI.

6. Are there any side effects?

Common side effects include blurred vision, eye pain, dry or itchy eye(s), feeling of temporary burning sensation or sharp, painful sensation in eye(s), swelling around the eye(s) or eyelids, eye irritation.

For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.



FULL CMI

LOMIDE® Eye Drops 0.1%

Active ingredient(s): lodoxamide trometamol


Consumer Medicine Information (CMI)

This leaflet provides important information about using Lomide. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about using Lomide.

Where to find information in this leaflet:

1. Why am I using Lomide?
2. What should I know before I use Lomide?
3. What if I am taking other medicines?
4. How do I use Lomide?
5. What should I know while using Lomide?
6. Are there any side effects?
7. Product details

1. Why am I using Lomide?

Lomide eye drops contains the active ingredient lodoxamide trometamol.

Lodoxamide trometamol belongs to a class of drugs called " Mast Cell Stabilisers." It works directly on mast cells and prevents allergic reaction to stimulants (e.g. pollen, dust) that cause conjunctivitis.

Lomide is used to treat seasonal allergic conjunctivitis, an eye problem which causes red, watery, and itchy eyes and/or eyelids. It is also used to treat vernal keratoconjunctivitis or spring catarrh (a severe allergic swelling of the eye with symptoms such as severe itching in eyes, sensitivity to light, eye discharge). It can be used as a preventive treatment against a seasonal allergic conjunctivitis.

2. What should I know before I use Lomide?

Warnings

Do not use Lomide if:

  • you are allergic to lodoxamide trometamol, or any of the ingredients listed at the end of this leaflet.
  • the expiry date has passed, the packaging is torn or the seal around the neck area is broken.

Do not use Lomide eye drops in children less than four years of age.

Always check the ingredients to make sure you can use this medicine.

Check with your doctor if you:

  • take any medicines for any condition.

Do not put Lomide eye drops in your eyes if you are wearing contact lenses as it may cause irritation to your eyes and discolor soft contact lenses.

Remove your contact lenses before putting Lomide eye drops and wait at least 15 minutes before you reinsert your contact Lense in your eyes.

Lomide eye drops are for Ophthalmic use only. Do not use for oral use or for the injection use.

Talk to your doctor if you are unsure about using Lomide eye drops.

During treatment, you may be at risk of developing certain side effects. It is important you understand these risks and how to monitor for them. See additional information under Section 6. Are there any side effects?

Pregnancy and breastfeeding

Check with your doctor if you are pregnant or intend to become pregnant.

Your doctor will advise you regarding the potential possible risks and benefits of using Lomide eye drops during pregnancy.

Talk to your doctor if you are breastfeeding or intend to breastfeed.

Your doctor will advise you regarding the potential possible risks and benefits of using Lomide eye drops during breast feeding.

3. What if I am taking other medicines?

Tell your doctor or pharmacist if you are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop.

Some medicines may interfere with Lomide eye drops and affect how it works.

Check with your doctor or pharmacist if you are not sure about what medicines, vitamins or supplements you are taking and if these affect Lomide eye drops.

4. How do I use Lomide?

How much to use

  • Your doctor will advise you the appropriate dose.
  • Use one drop in each eye, four times a day at regular intervals.
  • Follow the instructions provided and use Lomide eye drops until your doctor tells you to stop.
  • If you want to use any other eye drops, wait for 10 minutes after using Lomide eye drops.
  • Consult your doctor or pharmacist if your eye problem increases or symptoms do not improve within a few days after starting Lomide eye drops.
  • Lomide eye drops can be used as a preventive treatment against a seasonal allergic conjunctivitis (eye problem with symptoms such as red, watery, and itchy eyes and/or eyelids).
  • Your doctor will advise you regarding the treatment duration for the allergy season.

When to use Lomide

  • Lomide eye drops should be used at about the same time every day unless your doctor or pharmacist tells you otherwise.
  • Use Lomide eye drops at regular intervals to have the maximum effect.

How to use Lomide eye drops

  • Sitting or lying down might make putting your eye drops process simpler.
  • Remove contact lenses if you are wearing them before putting the eye drops in.
  • Shake the bottle well prior to use.

Follow below steps to use Lomide eye drops:

  • Wash your hands thoroughly with soap and water.
  • Before using a bottle for the first time, break the safety seal around the neck area and throw the loose plastic ring away.
  • Mix the contents of the bottle by inverting 5 to 10 times.
  • Remove the cap from the bottle.
  • Hold the bottle upside down in one hand between your thumb and middle finger (see Diagram 1).

Diagram 1

  • Tilt your head back, gently pull down the lower eyelid of your eye to form a pouch/pocket.
  • Place the tip of the bottle close to your eye. Do not touch the tip to your eye as this may cause injury to the eye
  • Do not touch the dropper tip to any surface to avoid contamination.
  • Release one drop into the pouch/pocket formed between your eye and eyelid by gently tapping or pressing the base of the bottle with your forefinger (see Diagrams 2 and 3).

Diagram 2

Diagram 3

  • Close your eye. Do not blink or rub your eye.
  • When your eye is closed, place your index finger against the inside corner of your eye and press against your nose for about two minutes. This will help to prevent the medicine from draining through the tear duct to the nose and throat, from where it can be absorbed into other parts of your body.
  • If necessary, repeat the above steps for the other eye.
  • It is normal for a small amount of the eye drop to spill onto your cheek since your eyelids can only hold less than one drop at a time. Wipe away any spillage with a tissue.
  • Replace the cap on the bottle, closing it tightly.
  • Always keep the bottle tightly closed when not in use.
  • Wash your hands again with soap and water to remove any residue.
  • Wash the child's hands, if you are using Lomide eye drops in a child's eye(s)
  • You may feel a temporary burning sensation or sharp, painful sensation or discomfort in the eye(s) shortly after using Lomide eye drops.
  • Contact your doctor, optometrist or pharmacist immediately if the symptoms persist for a long time.
  • If you want to wear your contact lenses, wait 15 minutes after instilling the dose before reinserting the contact lenses.
  • If you want to use any other eye drops, wait for 10 minutes after using Lomide eye drops.
  • Discard the eye drops after 28 days after opening it.

If you forget to use Lomide

Lomide eye drops should be used regularly at the same time each day. If you miss your dose at the usual time, use the eye drops as soon as you remember and then go back to using your eye drops as you would normally do.

If it is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to.

Do not take a double dose to make up for the dose you missed.

If you use too much Lomide

If you think that you have used too much Lomide eye drops, you may need urgent medical attention.

If you have accidentally put several drops in your eyes, immediately wash your eyes with warm water and consult your doctor.

If you have accidentally swallowed Lomide eye drops you should immediately:

  • phone the Poisons Information Centre
    (by calling 13 11 26), or
  • contact your doctor, or
  • go to the Emergency Department at your nearest hospital.

You should do this even if there are no signs of discomfort or poisoning.

5. What should I know while using Lomide?

Things you should do

Call your doctor straight away if you:

  • develop any signs of allergic reactions.
  • become pregnant while using Lomide eye drops.
  • feel any persisting burning sensation or painful sensation in your eyes or feel uncomfortable after putting eye drops in.
  • have increased eye problems or symptoms do not improve within a few days after starting Lomide eye drops.

Remind any doctor, dentist or pharmacist or optometrist you visit that you are using Lomide eye drops.

Things you should not do

  • Do not stop using this medicine suddenly.
  • Do not put Lomide eye drops in your eyes if you are wearing contact lenses as it may cause irritation to your eyes and discolor soft contact lenses.
  • Do not use Lomide eye drops in children less than four years of age.
  • Do not give Lomide eye drops to anyone else, even if they seem to have the same condition as you.
  • Do not use Lomide eye drops to treat other problems unless your doctor or pharmacist tells you to.

Driving or using machines

Be careful before you drive or use any machines or tools until you know how Lomide affects you.

Lomide eye drops may cause temporary blurred vision or other eye problems in some people.

Wait until the vision clears before driving or using machinery.

Looking after your medicine

  • Store below 25°C
  • Do not freeze the eye drops.
  • Do not leave the top off the bottle for any time. Put the top back on the bottle immediately after use to avoid any contamination.

Follow the instructions in the carton on how to take care of your medicine properly.

Store it in a cool, dry place away from moisture, heat or sunlight; for example, do not store it:

  • in the bathroom or near a sink, or
  • in the car or on window sills.

Keep it where young children cannot reach it.

When to discard your medicine

Discard any remaining eye drops after 28 days after opening it.

Getting rid of any unwanted medicine

If you no longer need to use this medicine or it is out of date, take it to any pharmacy for safe disposal.

Do not use this medicine after the expiry date.

6. Are there any side effects?

All medicines can have side effects. If you do experience any side effects, most of them are minor and temporary. However, some side effects may need medical attention.

See the information below and, if you need to, ask your doctor or pharmacist if you have any further questions about side effects.

Less serious side effects

Less serious side effectsWhat to do
Eye problems:
  • Allergic reaction having symptoms such as shortness of breath, difficulty in breathing, swelling of the face, lips, tongue or other parts of the body, rash.
  • Feeling of temporary burning sensation or sharp, painful sensation or uncomfortable feeling in eye(s) after using Lomide eye drops.
  • Itchy eye(s)
  • Blurred vision
  • Dry eye
  • Feeling of tiredness in eye(s)
  • Eye pain
  • Eye irritation
  • Eye discharge
  • Swelling around the eye(s) or eyelids.
  • Excessive secretion of tears from the eye(s)
General problems:
  • Headache
  • Feeling sick
  • Dizziness
  • Drowsiness
  • Dry nose
  • Sneezing
Speak to your doctor if you have any of these less serious side effects and they worry you.

Serious side effects

Serious side effectsWhat to do
Eye problems:
  • Excessive production of tears.
  • Swelling of the thin membrane (conjunctiva) that covers the white part of the eye (sclera)
  • Anterior chamber cells epitheliopathy (An eye problem characterized by multiple yellowish white or light-colored lesions that form in the retina)
  • Keratopathy (diseases of cornea/eyeball), keratitis (a disease of the cornea having symptoms such as eye pain, eye redness, blurred vision)
  • Blepharitis (eye condition causing swollen eyelid, eye irritation, crusting, eye redness)
  • Excessive opening of blood vessels of eye causing reddening of white portion of the eye (sclera) (ocular hyperaemia)
  • Sticky sensation in eye(s)
  • Corneal erosion, corneal abrasion (eye disorder having symptoms such as pain, irritation, redness in eye(s), blurred vision)
  • Corneal deposits (an eye condition that may cause decrease in vision)
  • Feeling that something is in your eye(s) (foreign body sensation)
Other problems:
  • Taste disturbance or loss of taste
  • Fast or irregular heartbeat.
Call your doctor straight away, or go straight to the Emergency Department at your nearest hospital if you notice any of these serious side effects.

Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.

Other side effects not listed here may occur in some people.

Reporting side effects

After you have received medical advice for any side effects you experience, you can report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems. By reporting side effects, you can help provide more information on the safety of this medicine.

Always make sure you speak to your doctor or pharmacist before you decide to stop taking any of your medicines.

7. Product details

This medicine is only available with a doctor's prescription.

What Lomide contains

Active ingredient
(main ingredient)
lodoxamide trometamol
Other ingredients
(inactive ingredients)
Mannitol, hypromellose, sodium citrate, citric acid monohydrate, tyloxapol, disodium edetate, benzalkonium chloride, hydrochloric acid, sodium hydroxide and water purified.
Potential allergensbenzalkonium chloride as a preservative

Do not take this medicine if you are allergic to any of these ingredients.

What Lomide looks like

Lomide Eye Drops are a clear, colourless sterile solution in an LDPE 10 mL dispenser bottle

Who distributes Lomide

Novartis Pharmaceuticals Australia Pty Limited
ABN 18 004 244 160
54 Waterloo Road
Macquarie Park NSW 2113
Telephone: 1-800-671-203
Web site: www.novartis.com.au

Australian registration numbers

Aust R No. 54275

® Registered Trademark

This leaflet was prepared in March 2025.

(lom120121c_V4 based on PI lom120121i_V2)

Published by MIMS June 2025

BRAND INFORMATION

Brand name

Lomide Eye Drops

Active ingredient

Lodoxamide

Schedule

S2

 

1 Name of Medicine

Lodoxamide trometamol.

2 Qualitative and Quantitative Composition

Lomide Eye Drops contain 1.78 mg/mL lodoxamide trometamol (equivalent to 1.0 mg/mL lodoxamide).

Excipients with known effect.

Benzalkonium chloride as a preservative.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

Eye Drops, a clear, colourless sterile solution for topical application to the eye.

4 Clinical Particulars

4.1 Therapeutic Indications

Seasonal allergic conjunctivitis and vernal keratoconjunctivitis in adults and children four years of age and older.
Prophylactic use of Lomide Eye Drops may help in the management of seasonal allergic conjunctivitis and assist in reducing the allergic symptoms.

4.2 Dose and Method of Administration

Adults and children 4 years and older.

One drop in each eye four times a day at regular intervals.
Patients who experience regular symptoms associated with seasonal allergic conjunctivitis should be advised to begin treatment with Lomide Eye Drops about one week prior to the expected onset of the allergy season(s). Treatment should be continued for the duration of the allergy season.
Patients should be advised that the effect of therapy with Lomide Eye Drops is dependent upon its administration at regular intervals, as directed.
Improvements in signs and symptoms in response to therapy with Lomide Eye Drops (decreased discomfort, itching, foreign body sensation, photophobia, acute ocular pain, tearing, discharge, erythema/ swelling, conjunctival redness, limbal reaction, epithelial disease, ptosis) are usually evident within a few days, however, longer treatment for up to four weeks is sometimes required. Further, continued treatment may result in ongoing improvement in signs and symptoms for at least 3 months. Once symptomatic improvement has been established, therapy should be continued for as long as needed to sustain improvement.
Patients should be advised to wait 10 minutes after instilling Lomide Eye Drops before instilling any other eye drops.

4.3 Contraindications

Known hypersensitivity to lodoxamide or any excipient.

4.4 Special Warnings and Precautions for Use

Lomide Eye Drops are not for injection.

Information for the patient.

Patients should be advised that effect of therapy with lodoxamide eye drops is dependent upon administration at regular intervals. The recommended frequency of administration should not be exceeded.
In situations where the condition does not improve within a few days, or unmanageable symptoms occur during treatment, the patient should be advised to consult a doctor or pharmacist.
Patients should also be advised that instillation of eye drops may cause discomfort or transient burning or stinging initially. Should these symptoms persist, the patient should be advised to contact a doctor, optometrist or pharmacist.
Due to the severe nature of the disease, patients should be advised not to wear contact lenses while being treated for vernal keratoconjunctivitis. In the event that a patient does wear soft contact lenses, the lenses should be removed prior to instillation of the drops and should not be re-inserted earlier than 15 minutes after dosing.
Lodoxamide eye drops should not affect a patient's ability to drive or to use machinery.

Contact lenses.

Lomide Eye Drops contain benzalkonium chloride which may cause eye irritation and are known to discolour soft contact lenses. Avoid contact with soft contact lenses. Patients must be instructed to remove contact lenses prior to application of Lomide Eye Drops and wait at least 15 minutes before reinsertion.

Paediatric use.

The safety and effectiveness of Lomide Eye Drops in children below the age of four years have not been established.

Use in the elderly.

There are no special precautions to be followed in prescribing Lomide Eye Drops for the elderly.

Effects on laboratory tests.

No data available.

4.5 Interactions with Other Medicines and Other Forms of Interactions

No specific drug interaction studies, either with ophthalmic or systemic medications, have been conducted. Limited concomitant medications, however, were permitted during the clinical studies and no interactions were observed. Concomitant medications included: corticosteroids (systemic and ophthalmic), naphazoline, antazoline, ketorolac, ciprofloxacin, gentamicin, sulfacetamide, tetracycline, tobramycin, timolol and dipivefrine.
Patients should be advised to wait 10 minutes after instilling Lomide Eye Drops before instilling any other eye drops.

4.6 Fertility, Pregnancy and Lactation

Effects on fertility.

No evidence of impairment of reproductive function was shown in laboratory animal studies.
There is no data available on the effect of lodoxamide on fertility in humans.
(Category B1)
Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human foetus having been observed. Studies in animals have not shown evidence of an increased occurrence of foetal damage.
Reproduction studies with lodoxamide trometamol administered orally to rats and rabbits in doses of 100 mg/kg/day produced no evidence of developmental toxicity. There are no or a limited amount of data from the use of Lomide Eye Drops in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. Because animal reproductive studies are not always predictive of human response, lodoxamide eye drops should only be used in pregnancy if clearly needed.
It is not known whether lodoxamide is excreted in human milk. There is insufficient information on the excretion of lodoxamide from Lomide Eye Drops in animal milk. A risk to the breastfed child cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/ abstain from Lomide Eye Drops therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman.

4.7 Effects on Ability to Drive and Use Machines

Temporary blurred vision or other visual disturbances may affect the ability to drive or use machines. If blurred vision occurs at instillation, the patient must wait until the vision clears before driving or using machinery.

4.8 Adverse Effects (Undesirable Effects)

Lomide Eye Drops were well tolerated in clinical studies with no significant changes in visual acuity, colour vision, intraocular pressure or signs of local toxicity or irritation. No serious adverse events were reported with the use of Lomide Eye Drops in these studies. Side effects were mild and self limiting, resolving within minutes without further intervention. The incidence of side effects was similar to other topical medications such as sodium cromoglycate, and only slightly greater than when the vehicle was used alone.
During clinical studies, the most frequently reported ocular adverse experiences were transient burning, stinging or discomfort upon instillation, which occurred in 13% of patients. Other ocular events occurring in 1 to 3.5% of the patients included ocular pruritus (3.5%), blurred vision (1.8%), lid margin crusting (1.6%), dry eye (1.3%), tearing (1.2%) and hyperaemia (1.2%). Events that occurred in less than 1% of the patients included foreign body sensation, ocular pain, discharge, ocular oedema, ocular fatigue, ocular warming sensation, lid oedema, chemosis, anterior chamber cells, epitheliopathy, keratopathy/ keratitis, blepharitis, sticky sensation, corneal erosion, dim vision, corneal abrasion and allergy.
Non-ocular events are rare and reported at incidences less than 0.5%. These included a temporary warm sensation, headache, nausea, stomach discomfort, dizziness, somnolence, dry nose, sneezing and rash.

Postmarketing experience.

The following adverse reactions are classified according to the following convention: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000) or not known (cannot be estimated from the available data). Within each frequency-grouping, adverse reactions are presented in order of decreasing seriousness. The adverse reactions have been observed during clinical trials and post-marketing experience for lodoxamide eye drops. See Table 1.
Additional adverse reactions identified from post-marketing surveillance include the following. Frequencies cannot be estimated from the available data. Within each system organ class adverse reactions are presented in order of decreasing seriousness. See Table 2.

Reporting suspected adverse effects.

Reporting suspected adverse reactions after registration of the medicinal product is important. It allows continued monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions at www.tga.gov.au/reporting-problems.

4.9 Overdose

Due to the characteristics of this preparation, toxic effects are unlikely following an ocular overdose of this product. In the event of an ocular overdose, flush from the eye with lukewarm water.
In case of accidental ingestion of doses of 0.1 mg to 10.0 mg of lodoxamide, the following adverse effects may occur: feeling of warmth, flushing, nausea, vomiting, diaphoresis and abdominal cramping. Transient elevations of systolic and diastolic blood pressure have been noted with doses of 3.0 and 10.0 mg of oral lodoxamide, but they resolve spontaneously after a short time. Other possible adverse effects after an oral overdose are headache, dizziness, fatigue and loose stools.
If accidentally ingested, efforts to decrease further absorption may be appropriate.
For information on the management of overdose, contact the Poison Information Centre on 13 11 26 (Australia).

5 Pharmacological Properties

5.1 Pharmacodynamic Properties

Mechanism of action.

Lodoxamide trometamol is a mast cell stabiliser that inhibits the in vivo type I, IgE-mediated (immediate) hypersensitivity reaction. Lodoxamide inhibits the increase in cutaneous vascular permeability that is associated with reagin or IgE and antigen-mediated reactions.
In vitro studies have demonstrated the ability of lodoxamide to stabilise rodent mast cells and prevent antigen-stimulated release of histamine. In addition, lodoxamide prevents the release of other mast cell inflammatory mediators (i.e. SRS-A, slow-reacting substances of anaphylaxis also known as the peptido-leukotrienes) and inhibits eosinophil chemotaxis. Although lodoxamide's precise mechanism of action is unknown, the drug has been reported to prevent calcium influx into mast cells upon antigen stimulation.
Lodoxamide has no intrinsic vasoconstrictor, antihistaminic, cyclo-oxygenase inhibition or other anti-inflammatory activity.

Clinical trials.

The safety (915 patients) and efficacy (723 patients) of Lomide Eye Drops in the treatment of allergic ocular disorders were studied in a series of nine clinical studies; 336 of the patients evaluated for safety were treated for seasonal allergic conjunctivitis while 389 of the patients evaluated for safety were treated for vernal keratoconjunctivitis. Patients four years of age and older were enrolled, with no upper age limit. The demographic features of the study population reflected the expected age-sex distribution of the conditions studied.
Fifty six patients were treated up to 12 months, with no evidence of rebound exacerbation of disease on cessation of therapy or tachyphylaxis.

Seasonal allergic conjunctivitis.

Lomide Eye Drops were demonstrated to be at least as efficacious as sodium cromoglycate 2% and 4% in the treatment of seasonal allergic conjunctivitis with significant improvement in many symptoms and signs occurring within the first three to seven days of treatment. Treatment effect continued to increase up to 4 weeks after initiation of therapy.

Vernal keratoconjunctivitis.

Lomide Eye Drops were shown to be superior to placebo and sodium cromoglycate 2% and 4% in the treatment of vernal keratoconjunctivitis with resolution of some of the major clinical signs (corneal papillae, follicles and corneal staining) of this condition. In a 7-week study Lomide Eye Drops significantly reduced the need for adjunctive topical steroid therapy in patients with moderate to severe vernal keratoconjunctivitis in comparison to sodium cromoglycate 2% (week 3-week 7 of the study).

5.2 Pharmacokinetic Properties

The disposition of 14C-lodoxamide was studied in six healthy adult volunteers receiving a 3 mg (50 microCi) oral dose of lodoxamide. Urinary excretion was the major route of elimination (83%). The elimination half-life of 14C-lodoxamide was estimated from urinary excretion data to be 8.5 hours.
The administration of Lomide Eye Drops to twelve healthy adult volunteers (one drop in each eye four times per day for ten days) resulted in only 3 plasma samples (from a total of 108) with detectable levels of lodoxamide (level of detection 2.5 nanogram/mL). It is, therefore, possible that minute amounts of lodoxamide might be absorbed systemically in some patients.

5.3 Preclinical Safety Data

Carcinogenicity.

A long-term study with lodoxamide trometamol in rats (two-year oral administration) showed no neoplastic or tumourigenic effects at doses up to 100 mg/kg/day (more than 5,000 times the proposed human clinical dose).

Genotoxicity.

No evidence of mutagenicity or genetic damage was seen in assays for gene mutations and chromosomal damage. In the BALB/c-3T3 cells transformation assay, some increase in the number of transformed foci was seen at high concentrations.

6 Pharmaceutical Particulars

6.1 List of Excipients

Mannitol, hypromellose, sodium citrate, citric acid monohydrate, tyloxapol, disodium edetate, benzalkonium chloride, hydrochloric acid, sodium hydroxide and water-purified.

6.2 Incompatibilities

No data available.

6.3 Shelf Life

In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.

6.4 Special Precautions for Storage

Store below 25°C. Do not freeze.
Discard 28 days after opening.

6.5 Nature and Contents of Container

Lomide Eye Drops 0.1% are a clear, colourless solution in an LDPE 10 mL dispenser bottle.

6.6 Special Precautions for Disposal

In Australia, any unused medicine or waste material should be disposed of by taking to your local pharmacy.

6.7 Physicochemical Properties

Lodoxamide trometamol is a white crystalline powder, freely soluble in water.

Chemical structure.


Molecular weight: 553.91.
Empirical formula: C19H28O12N5Cl.
Chemical names: Lodoxamide: N,N'-(2-chloro-5-cyano-m-phenylene) dioxamic acid.
Trometamol: 2-amino-2-(hydroxymethyl)-1,3-propanediol.

CAS number.

CAS-63610-09-3.

7 Medicine Schedule (Poisons Standard)

Pharmacy Only Medicine (Schedule 2).

Summary Table of Changes